Relapsing polychondritis, smouldering non-secretory myeloma and early myelodysplastic syndrome in the same patient: Three difficult diagnoses produce a life threatening illness

Leukemia Research

Volumn 24, Issue 1, 2000, Pages 91-93

  Hall, Rachel ^a   Hopkinson, Neil ^a   Hamblin, Terry ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Immunoglobulins; Myeloma; Polychondritis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYELODYSPLASTIC SYNDROME; MYELOMA; POLYCHONDRITIS; PRIORITY JOURNAL; RECURRENT DISEASE;

AGED; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ERYTHEMA; FATAL OUTCOME; HUMANS; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; POLYCHONDRITIS, RELAPSING; PRURITUS; VENOUS THROMBOSIS;

EID: 0033990693     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00151-4     Document Type: Article

References (18)

1. Bergsagel D.E. Plasma cell neoplasms and acute leukaemia. Clin. Haematol. 11:1982;221-234.
2. Mufti G.J., Hamblin T.J., Clein G.P., Race C. Coexistent myelodysplasia and plasma cell neoplasia. Br. J. Haematol. 54:1983;91-96.
3. Copplestone J.A., Mufti G.J., Hamblin T.J., Oscier D.G. Immunological abnormalities in myelodysplastic syndromes. II Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. Br. J. Haematol. 63:1986;149-159.
4. Mufti G.J., Figes A., Hamblin T.J., Oscier D.G., Copplestone J.A. Immunological abnormalities in myelodysplastic syndromes. I Serum immunoglobulins and autoantibodies. Br. J. Haematol. 63:1986;143-147.
5. Trentham D.E., Le C.H. Relapsing polychondritis. Ann. Int. Med. 129:1998;114-122.
6. Lang B., Rothenfusser A., Lanchbury J.S. et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 36:1993;660-664.
7. Foidart J.M., Abe S., Martin G.R. et al. Antibodies to type II collagen in relapsing polychondritis. New Engl. J. Med. 299:1978;1203-1207.
8. Michet J.C., McKenna C.H., Luthra H.S. et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann. Int. Med. 104:1986;74-78.
9. Mongin M., Gabriel B., Weiller P.J. Relapsing polychondritis and associated pathology. Bull. Acad. Nat. Med. 172:1988;109-113.
10. Arlet P., Pris J., Sallerin F., Villain C., Laroche M., Le Tallec Y. Relapsing polychondritis: clinical features. Presse. Med. 18:1989;157-160.
11. Tanaka K., Nakamura E., Naitoh K. Relapsing polychondritis in a patient with myelodysplastic syndrome. Rinsho. Ketsueki. 31:1990;1851-1855.
12. Riche O. et al. Chronic relapsing polychondritis: visceral manifestations and associated pathology. Sem. Hop. Paris. 61:1991;5-13.
13. Van Besien K.V., Tricot G., Hoffman R. Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am. J. Hematol. 40:1992;47-50.
14. Lavabre-Bertrand T., Navarro M. Relapsing polychondritis and myelodysplastic syndrome. Am. J. Hematol. 43:1993;243.
15. Shirota T., Hayashi O., Uchida H., Tonozuka N., Sakai N., Itoh H. Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anaemia to chronic myelomonocytic leukemia. Ann. Hematol. 67:1993;45-47.
16. Diebold J., Rauh G., Jager K., Lohrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br. J. Haematol. 89:1995;820-830.
17. Hebbar M., Broillard M., Wattel E. et al. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia. 9:1995;731-733.
18. Hamblin T.J. Immunological abnormalities in myelodysplastic syndromes. Sem. Hematol. 33:1996;150-162.